Locations:
SearchAdvertisement
How to combat the rise in mortality when patients become adults
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients
Two-year event-free survival comparable to matched sibling donor myeloablative transplant
3 pediatric gastroenterologists discuss advances in their diagnostic toolkits
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival
Early projects include predicting cardiac arrest, kidney injury and low cardiac output syndrome after surgery
JAMA study adds new data to decades-long guidance
Chemicals in e-cigarettes weaken the epithelial barrier in airways
What factors can be modified to improve outcomes?
New course highlights role of imaging in the diagnosis and management in TOF
Advertisement
Advertisement